Human papillomavirus vaccination and respect for children's developing autonomy: Results from a European Union wide study.
Child health
Europe
papillomavirus vaccines
personal autonomy
vaccination
vaccination coverage
Journal
Journal of child health care : for professionals working with children in the hospital and community
ISSN: 1741-2889
Titre abrégé: J Child Health Care
Pays: England
ID NLM: 9806360
Informations de publication
Date de publication:
09 2019
09 2019
Historique:
pubmed:
28
5
2019
medline:
23
6
2020
entrez:
29
5
2019
Statut:
ppublish
Résumé
Children's rights to autonomy of choice are differently expressed throughout Europe. We explored differences regarding expressions of respect for children's autonomy throughout Europe, using the procedure of human papillomavirus (HPV) vaccination offer as indicator. We used a mixed methods approach, utilizing an expert survey within the frame of "Models of Child Health Appraised" (MOCHA), among all 30 European Union (EU) and European Economic Area states. A questionnaire was designed using vignettes regarding the vaccine provision. Thirty MOCHA country agents were invited to respond from June 2017 to April 2018. In total, 28 country agents responded. We studied the following themes: (i) provision of informed consent, (ii) parental and medical paternalism, (iii) relevance of the child's chronological age or maturity, and (iv) vaccination programs targeting boys. These are being handled differently across the region. We explored associations of these implemented practices with the national vaccine coverage rate across Europe. We used the processes of HPV vaccination to study child's autonomy, the paradigm change toward libertarian paternalism and issues of sex-equity. Interestingly, greater respect for children's autonomy tends to be associated with medium or high vaccination coverage rates and lower respect with lower rates. Respect and empowerment seem to have practical as well as moral benefits. Identifying and transferring the most suitable ethical approaches is crucial and should be strengthened.
Identifiants
pubmed: 31132868
doi: 10.1177/1367493519852476
pmc: PMC6716421
doi:
Substances chimiques
Papillomavirus Vaccines
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Pagination
343-357Références
Qual Health Res. 2005 Nov;15(9):1277-88
pubmed: 16204405
Vaccine. 2015 Mar 30;33(14):1673-81
pubmed: 25720792
Stud Health Technol Inform. 2017;235:53-57
pubmed: 28423754
BMC Med Ethics. 2015 Nov 09;16(1):76
pubmed: 26553304
BMJ. 2016 Jun 15;353:i3372
pubmed: 27311706
Implement Sci. 2018 Jun 26;13(1):88
pubmed: 29941011
Vaccine. 2018 Aug 9;36(33):4979-4992
pubmed: 30037416
Int J Integr Care. 2017 Apr 24;17(2):1
pubmed: 28970742
Milbank Q. 2004;82(4):581-629
pubmed: 15595944
BMJ. 2017 Jul 20;358:j3523
pubmed: 28729285
Arch Argent Pediatr. 2018 Jun 1;116(3):e401-e408
pubmed: 29756714
Euro Surveill. 2008 Jan 24;13(4):null
pubmed: 18445398